Correlation Between BlueScope Steel and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both BlueScope Steel and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BlueScope Steel and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BlueScope Steel Limited and Transcode Therapeutics, you can compare the effects of market volatilities on BlueScope Steel and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BlueScope Steel with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BlueScope Steel and Transcode Therapeutics.
Diversification Opportunities for BlueScope Steel and Transcode Therapeutics
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between BlueScope and Transcode is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding BlueScope Steel Limited and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and BlueScope Steel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BlueScope Steel Limited are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of BlueScope Steel i.e., BlueScope Steel and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between BlueScope Steel and Transcode Therapeutics
Assuming the 90 days horizon BlueScope Steel is expected to generate 1.72 times less return on investment than Transcode Therapeutics. But when comparing it to its historical volatility, BlueScope Steel Limited is 11.74 times less risky than Transcode Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 1,181 in Transcode Therapeutics on April 26, 2025 and sell it today you would lose (81.00) from holding Transcode Therapeutics or give up 6.86% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 45.9% |
Values | Daily Returns |
BlueScope Steel Limited vs. Transcode Therapeutics
Performance |
Timeline |
BlueScope Steel |
Risk-Adjusted Performance
Good
Weak | Strong |
Transcode Therapeutics |
BlueScope Steel and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BlueScope Steel and Transcode Therapeutics
The main advantage of trading using opposite BlueScope Steel and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BlueScope Steel position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.BlueScope Steel vs. Nucor Corp | BlueScope Steel vs. Reliance Steel Aluminum | BlueScope Steel vs. ArcelorMittal SA ADR | BlueScope Steel vs. Commercial Metals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |